Goldman Sachs Group »

Foghorn Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Foghorn Therapeutics (FHTX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Foghorn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Foghorn Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Foghorn Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $92k 14k 6.45
2023-09-30 $80k 16k 5.00
2023-06-30 $107k 15k 7.04
2023-03-31 $193k 31k 6.20
2022-12-31 $216k 34k 6.38
2022-06-30 $223k 16k 13.62
2022-03-31 $200k 13k 15.21
2021-12-31 $833k 36k 22.86
2021-09-30 $178k 13k 13.90
2020-12-31 $220k 11k 20.29